Raffles Medical Group Ltd (SGX:BSL)
Singapore flag Singapore · Delayed Price · Currency is SGD
0.9300
-0.0150 (-1.59%)
Jun 19, 2026, 5:04 PM SGT

Raffles Medical Group Stock Forecast

Stock Price Forecast

According to 7 analysts polled by S&P Global, Raffles Medical Group stock has a consensus rating of "Strong Buy" and an average price target of $1.22. The average 1-year stock price forecast is 31.18% higher than the current stock price, while the lowest is $1.02 (+9.68%) and the highest is $1.30 (+39.78%).

Price Target: $1.22 (+31.18%)
Analyst Consensus: Strong Buy
TargetLowAverageMedianHigh
Price$1.02$1.22$1.25$1.30
Change+9.68%+31.18%+34.41%+39.78%
* Price targets were last updated on Feb 25, 2026.

Analyst Ratings

The average analyst rating for Raffles Medical Group stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.

Recommendation Trends

RatingAug '25Oct '25Nov '25Jan '26Feb '26Mar '26
Strong Buy334445
Buy111111
Hold221111
Sell000000
Strong Sell000000
Total666667

Latest Forecasts

AnalystFirmRatingRatingActionPrice TargetUpsideDate
Phillip Securities
Phillip Securities
Hold
Maintains
$1.02
HoldMaintains$1.02+9.68%Feb 25, 2026
UOB Kay Hian
UOB Kay Hian
Buy
Maintains
$1.25
BuyMaintains$1.25+34.41%Feb 24, 2026
Unknown Analyst
Lim & Tan Securities
No rating
Lim & Tan Securities
Buy
Maintains
$1.20
BuyMaintains$1.20+29.03%Feb 23, 2026
DBS
DBS
Buy
Maintains
$1.25
BuyMaintains$1.25+34.41%Feb 23, 2026
CGS International
CGS International
Buy
Reiterates
$1.23
BuyReiterates$1.23+32.26%Jan 6, 2026
More Analyst Ratings

Financial Forecast

Revenue This Year
796.30M
from 765.57M
Increased by 4.01%
Revenue Next Year
832.29M
from 796.30M
Increased by 4.52%
EPS This Year
0.04
from 0.04
Decreased by -0.35%
EPS Next Year
0.04
from 0.04
Increased by 7.68%
Fiscal YearFY 2021FY 2022FY 2023FY 2024FY 2025FY 2026
Period EndingDec 31, 2021Dec 31, 2022Dec 31, 2023Dec 31, 2024Dec 31, 2025Dec 31, 2026
Revenue
725.23M824.95M708.04M752.43M765.57M796.30M
Revenue Growth
27.64%13.75%-14.17%6.27%1.75%4.01%
Gross Profit
194.99M400.10M315.94M339.03M347.31M731.20M
Gross Margin
26.89%48.50%44.62%45.06%45.37%91.82%
Operating Income
118.20M213.26M108.19M85.10M85.97M93.87M
Net Income
84.17M143.21M90.15M62.24M70.57M72.82M
EPS
----0.040.04
EPS Growth
----18.47%-0.35%
Forward PE
45.6724.5221.3921.3625.6923.59
Dividend / Share
0.020.040.020.030.030.03
Dividend Growth
-111.11%-36.84%4.17%20.00%0.67%
Free Cash Flow
82.13M113.84M193.49M57.61M44.46M115.85M
No. Analysts
-----7
EPS and Forward PE are based on non-GAAP adjusted numbers. Financial currency is SGD.

Revenue Forecast

Revenue202620272028
High815.0M
Avg796.3M
Low779.0M

Revenue Growth

Revenue Growth202620272028
High
6.5%
Avg
4.0%
Low
1.8%

EPS Forecast

EPS202620272028
High-
Avg0.04
Low-

EPS Growth

EPS Growth202620272028
High-
Avg
-0.4%
Low-